The subsequent section examines the evidence linking GIGYF2 to specific pathological conditions, including metabolic diseases, vascular aging, viral infections, and neurodegenerative disorders, thereby elucidating the clinical implications of this molecular regulator. Here, GIGYF2 is linked to metabolic disease.